All News Zynex, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
11.21 ^USD	+2.47%		-1.49%	+2.94%

01/03	RBC Raises Price Target on Zynex to $15 From $13, Keeps Outperform Rating	MT
29/02	Zynex, Inc. Provides Earnings Guidance First Quarter and Full Year 2024	CI

Zynex Sets First Quarter 2024 Earnings Call	18/04	PR
Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award	02/04	PR
Zynex Reports Fourth Quarter and Full Year 2023 Financial Results	01/03	AQ
RBC Raises Price Target on Zynex to $15 From $13, Keeps Outperform Rating	01/03	MT
Zynex, Inc. Provides Earnings Guidance First Quarter and Full Year 2024	01/03	CI
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on September 11, 2023.	01/03	CI
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on November 1, 2023.	01/03	CI
Zynex, Inc. announces an Equity Buyback for $20 million worth of its shares.	01/03	CI
Transcript : Zynex, Inc., Q4 2023 Earnings Call, Feb 29, 2024	01/03
Earnings Flash (ZYXI) ZYNEX Reports Q4 Revenue $47.3M, vs. Street Est of $55.6M	01/03	MT
Zynex, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	01/03	CI
Zynex, Inc. authorizes a Buyback Plan.	29/02	CI
Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call	22/02	PR
Zynex Introduces New Products	20/02	PR
Zynex, Inc. Introduces New Products	20/02	CI
Zynex Receives FDA Clearance for its Next Generation NMES Device	07/02	AQ
Zynex Receives US FDA Approval for Muscle Stimulation Device	06/02	MT
Zynex, Inc. Receives FDA Clearance for its Next Generation NMES Device	06/02	CI
Zynex Recognized in Top 25 Medical Device Companies for 2024	02/02	PR
Zynex to Participate at the Needham Annual Growth Conference	08/01	PR

No results for this search